Share this article
LUND, SWEDEN, September 7, 2026 – TFS HealthScience (TFS) has been awarded a Gold Medal in its 2026 EcoVadis sustainability assessment. The Contract Research Organization (CRO) scored 84 out of 100, a 14-point jump from last year’s score of 70. That places TFS in the 97th percentile, among the top 3% of every company EcoVadis rates worldwide.
“This result shows how central sustainability has become to how we operate. It shapes the decisions we make, the risks we manage and the value we build for our sponsors.”
Markus Granlund, Chief Executive Officer
Since its previous assessment, TFS improved across all four EcoVadis themes: Environment (+17 points), Labour and Human Rights (+16), Ethics (+13) and Sustainable Procurement (+8). The gains came from years of work: stronger governance, updated policies, deeper supplier checks and closer stakeholder engagement. Sustainability now factors into how TFS makes decisions and manages risk, not just how it reports.
“Sustainability is a team effort. Progress like this comes from everyone understanding how their everyday decisions add up. Close collaboration, stronger foundations, and a drive for continuous improvement got us here, and this result reflects that work.”
Nicole Bezuidenhout, Sustainability and Communications Manager
The Gold Medal builds on a year of measurable progress across TFS’s environmental, social and governance programme, detailed in the company’s ninth annual Sustainability Report. Below are a few environmental highlights:
SBTi
Near-term and net-zero targets validated by the Science Based Targets initiative
−17%
Total emissions down against 2024
99%
Renewable electricity sourcing, up from 62%
C → B
CDP Climate Change rating, with four leadership-level scores
For sponsors, the EcoVadis Gold Medal is independent recognition of how TFS operates. It also lines up with the ESG priorities of parent company Ratos AB: transparency, risk management and long-term value creation.
About TFS HealthScience
We are a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 40 countries, TFS provides tailored strategic resourcing solutions and clinical development services in specialized therapeutic areas, including dermatology, internal medicine, neuroscience, oncology and ophthalmology. Dedicated to securing the clinical path from science to life, we deliver successful trials by protecting our sponsor’s science and being radically honest with them along the way.
For more information, visit www.tfscro.com.
About EcoVadis
EcoVadis is a global provider of business sustainability ratings, intelligence and collaborative performance improvement tools. Its methodology covers environment, labour and human rights, ethics and sustainable procurement, and provides actionable sustainability scorecards to more than 130,000 rated companies across 180 countries.
Media contact
Paloma Redondo
Director, Marketing and Communications.